Impact of lymph node dissection on cancer-specific survival in non-small cell lung cancer patients: a SEER database analysis.
Ziran ZhaoYibo GaoFeng-Wei TanQi XueShugeng GaoJie HePublished in: Translational lung cancer research (2024)
The study findings suggest that LND plays a critical role in improving cancer-specific survival in NSCLC patients, particularly when tailored to the early stages of the disease. The optimal range of lymph nodes examined, between 24 and 32, offers crucial insights for personalized NSCLC treatment strategies and may enhance overall survival. These results underscore the need for refined surgical guidelines that incorporate the extent of LND, supporting the utility of a more personalized approach in NSCLC management.
Keyphrases
- end stage renal disease
- small cell lung cancer
- lymph node
- ejection fraction
- newly diagnosed
- chronic kidney disease
- papillary thyroid
- prostate cancer
- peritoneal dialysis
- advanced non small cell lung cancer
- early stage
- patient reported outcomes
- radiation therapy
- lymph node metastasis
- radical prostatectomy
- squamous cell
- data analysis
- electronic health record